Pharma ETFs Boosted by Mylan’s Giant Offer for Perrigo

Pharmaceuticals exchange traded funds are once again at the epicenter of the healthcare mergers and acquisitions as generic drugmaker Mylan (NYSE: MYL) has offered to acquire Israeli rival Perrigo (NYSE: PRGO) for $205 per share, or $28.86 billion. Mylan’s cash-and-stock offer comes at a...